FDA Drug Application (020220) for ULTRAVIST 300 by BAYER HLTHCARE

Back to FDA Applications sponsored by BAYER HLTHCARE

Application Number020220
Product Number002
FormINJECTABLE;INJECTION
Dosage62.3%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameULTRAVIST 300
Active IngredientIOPROMIDE

Active IngredientCount
List of drugs with Active Ingredient IOPROMIDE6


Back to FDA Applications sponsored by BAYER HLTHCARE